AMICUS THERAPEUTICS, INC. — Director's Dealing 2010

Jun 17, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2010-06-15

Reporting Person: Patterson Matthew R (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-06-15	Stock Options (right to buy)	$2.81	A	30000	Acquired	2020-06-15	Common Stock (30000)	Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on June 15, 2011. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on July 1, 2011, with a final installment vesting on June 1, 2014.